Search research articles
Contact Us
Filters
Showing results (11-20 of 27) with videos related to
Page
of 3
Sort By:
Magnetic Resonance Imaging
|
January 1, 1985
Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience
G E Wesbey, R C Brasch, H I Goldberg, et al.
Magnetic Resonance in Medicine
|
March 1, 1992
Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain
D L White, K P Aicher, A A Tzika, et al.
Radiology
|
October 1, 1983
Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions
G E Wesbey, R C Brasch, B L Engelstad, et al.
Radiology
|
April 1, 1983
Nuclear magnetic resonance imaging of the adrenal gland: a preliminary report
K L Moon, H Hricak, L E Crooks, et al.
Magnetic Resonance Imaging
|
January 1, 1985
Magnetic field dependence of spin-lattice relaxation enhancement using piperidinyl nitroxyl spin-labels
J D Lovin, G E Wesbey, B L Engelstad, et al.
Investigative Radiology
|
January 1, 1989
Rapid, contrast-enhanced, diuretic magnetic resonance imaging of unilateral partial ureteral obstruction. An experimental study in micropigs
A A Tzika, S Thurnher, H Hricak, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 1, 1991
Comparison of Fe-HBED and Fe-EHPG as hepatobiliary MR contrast agents
B Hoener, B L Engelstad, E C Ramos, et al.
AJR. American Journal of Roentgenology
|
January 1, 1989
Superparamagnetic iron oxide: pharmacokinetics and toxicity
R Weissleder, D D Stark, B L Engelstad, et al.
Investigative Radiology
|
March 1, 1987
Hepatobiliary magnetic resonance contrast agents assessed by gadolinium-153 scintigraphy
B L Engelstad, D L White, J P Huberty, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)
|
October 1, 1991
Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma
K K Matthay, J P Huberty, R S Hattner, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 27) with videos related to
Sort By:
Page
of 3
Magnetic Resonance Imaging
|
January 1, 1985
Dilute oral iron solutions as gastrointestinal contrast agents for magnetic resonance imaging; initial clinical experience
G E Wesbey, R C Brasch, H I Goldberg, et al.
Magnetic Resonance in Medicine
|
March 1, 1992
Iron-dextran as a magnetic susceptibility contrast agent: flow-related contrast effects in the T2-weighted spin-echo MRI of normal rat and cat brain
D L White, K P Aicher, A A Tzika, et al.
Radiology
|
October 1, 1983
Nuclear magnetic resonance contrast enhancement study of the gastrointestinal tract of rats and a human volunteer using nontoxic oral iron solutions
G E Wesbey, R C Brasch, B L Engelstad, et al.
Radiology
|
April 1, 1983
Nuclear magnetic resonance imaging of the adrenal gland: a preliminary report
K L Moon, H Hricak, L E Crooks, et al.
Magnetic Resonance Imaging
|
January 1, 1985
Magnetic field dependence of spin-lattice relaxation enhancement using piperidinyl nitroxyl spin-labels
J D Lovin, G E Wesbey, B L Engelstad, et al.
Investigative Radiology
|
January 1, 1989
Rapid, contrast-enhanced, diuretic magnetic resonance imaging of unilateral partial ureteral obstruction. An experimental study in micropigs
A A Tzika, S Thurnher, H Hricak, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 1, 1991
Comparison of Fe-HBED and Fe-EHPG as hepatobiliary MR contrast agents
B Hoener, B L Engelstad, E C Ramos, et al.
AJR. American Journal of Roentgenology
|
January 1, 1989
Superparamagnetic iron oxide: pharmacokinetics and toxicity
R Weissleder, D D Stark, B L Engelstad, et al.
Investigative Radiology
|
March 1, 1987
Hepatobiliary magnetic resonance contrast agents assessed by gadolinium-153 scintigraphy
B L Engelstad, D L White, J P Huberty, et al.
Journal of Nuclear Biology and Medicine (Turin, Italy : 1991)
|
October 1, 1991
Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma
K K Matthay, J P Huberty, R S Hattner, et al.
Page
of 3